BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5119520)

  • 1. Cytembena treatment of advanced gynaecological carcinomas.
    Dvorák O
    Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(3):289-98. PubMed ID: 5093948
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W; Preibsche W; Marzotko F
    Arch Geschwulstforsch; 1973; 41(3):241-7. PubMed ID: 4732846
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D
    Clin Obstet Gynaecol; 1978 Dec; 5(3):709-27. PubMed ID: 367674
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences in the cytostatic treatment of cancer originating in the genitalia].
    Váczy L
    Zentralbl Gynakol; 1965 Jul; 87(31):1075-82. PubMed ID: 5838635
    [No Abstract]   [Full Text] [Related]  

  • 7. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD
    Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of some inherited blood characters, changes in fifth fraction of serum lactate dehydrogenase, and resistance to cytembena in women with gynaecological carcinoma.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(2):219-24. PubMed ID: 5577318
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatic treatment of genital carcinoma].
    Limburg H
    Zentralbl Gynakol; 1969 Sep; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proliferative kinetics of human genital carcinoma following the action of cytostatics and hormones in in vivo tests].
    Heckmann U; Hamann A; Inamoto E
    Zentralbl Gynakol; 1969 Aug; 91(33):1057-61. PubMed ID: 5368199
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG; Ullery JC; Pace W
    Ohio State Med J; 1971 Aug; 67(8):721-5. PubMed ID: 4105456
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term administration of cytembena and cyclophosphamide to patients with gynaecological carcinoma. (Evaluation ff laboratory examinations).
    Jandová A; Skoda V; Novotná J; Pezlarová I; Pick P
    Neoplasma; 1971; 18(2):197-218. PubMed ID: 5280733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of clinical study of cytembena].
    Karev NI; Gorbunova VA; Gurevich BS; Koliadina PI; Monul FA
    Vopr Onkol; 1976; 22(10):84-5. PubMed ID: 1037040
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance formation in the cytostatic treatment of carcinomas].
    Heckmann U; Tranckjer AS; Harms J
    Zentralbl Gynakol; 1969 Sep; 91(37):1204-10. PubMed ID: 5368211
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer treatment with sulfones.
    Graham J; Graham R
    Surg Gynecol Obstet; 1969 Jul; 129(1):103-7. PubMed ID: 5790690
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of bacterial flora in the vagina and urine in patients with gynecologic neoplasms during short-term administration of cytostatics].
    Jandovà A; Novotnà J; Skoda V; Trnka V
    Cesk Gynekol; 1973 Jul; 38(6):420-2. PubMed ID: 4731601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.